Drugs that contain Bazedoxifene Acetate; Estrogens, Conjugated
1. Drug name - DUAVEE
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7683051 | WYETH PHARMS | Crystalline polymorph of bazedoxifene acetate |
Mar, 2027
(4 years from now) | |
| CN1938272A | WYETH PHARMS | The Crystal Polymorphic Form Of The Bazedoxifene Acetate |
Jan, 2010
(12 years ago) | |
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6479535 | WYETH PHARMS | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations |
May, 2024
(1 year, 7 months from now) | |
Treatment: Prevention of postmenopausal osteoporosis; treatment of moderate to severe vasomotor symptoms associated with menopause
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 20MG BASE;0.45MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.